116.79
2.92%
3.31
Dopo l'orario di chiusura:
116.78
-0.01
-0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott Laboratories set for stellar Q4 2024 earnings amid optimism for 2025 (NYSE:ABT) - Seeking Alpha
Abbott Laboratories (NYSE:ABT) Given "Outperform" Rating at Royal Bank of Canada - MarketBeat
Body Area Network Business Research Report 2024: Global Market to Reach $131 Billion by 2030, Fueled by Expansion of IoT-Enabled Wearables in Consumer and Medical - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) Shares Bought by Atomi Financial Group Inc. - MarketBeat
Transform Wealth LLC Acquires 3,875 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Structural Heart Devices Market Set to Witness Significant Growth by 2024-2031 | Abbott Laboratories, - EIN News
Lmcg Investments LLC Sells 9,515 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Ballentine Partners LLC Has $4.93 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Saudi Arabia IVD Market Outlook & Company Analysis - GlobeNewswire
Antacid Medications Market Is Booming Worldwide 2025-2032 | - openPR
Short Interest in Abbott Laboratories (NYSE:ABT) Increases By 18.3% - MarketBeat
Abbott Stock Ahead of Q4 Earnings Results: Smart Buy or Risky Move? - Nasdaq
Abbott Laboratories (NYSE:ABT) Shares Purchased by LVW Advisors LLC - MarketBeat
MassMutual Private Wealth & Trust FSB Sells 3,245 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Week ahead: Trump inauguration, initial jobless claims in focus - Proactive Investors USA
Annex Advisory Services LLC Purchases 3,177 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Arkadios Wealth Advisors Sells 3,749 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Carotid Stent Market Overall Study Report 2025-2032 | Abbott Laboratories, B. Braun SE, Biotronik SE & Co KG - openPR
Jury sides with Abbott Laboratories in ongoing fight over preterm infant formulas - AOL
Abbott Laboratories (NYSE:ABT) Shares Purchased by Financial & Tax Architects LLC - MarketBeat
HB Wealth Management LLC Purchases 14,259 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Verity & Verity LLC Increases Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Lummis Asset Management LP Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Integrated Investment Consultants LLC Acquires 11,475 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Folger Nolan Fleming Douglas Capital Management Inc. Sells 3,851 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Lifted by Brooklyn Investment Group - MarketBeat
Aaron Wealth Advisors LLC Has $1.47 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Looking to the Future: Why Abbott Laboratories is a Must-Watch Stock - Jomfruland.net
Jim Cramer on Abbott Laboratories (ABT): ‘I Think Abbott Will Win These Baby Formula Cases’ - Insider Monkey
9 Stocks on Jim Cramer’s Radar - Insider Monkey
5,660 Shares in Abbott Laboratories (NYSE:ABT) Bought by Sax Wealth Advisors LLC - MarketBeat
Merit Financial Group LLC Buys 7,316 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Hennion & Walsh Asset Management Inc. Has $1.45 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Trust Co. of Vermont Sells 9,600 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Biomarker Industry Market is Booming Worldwide | Abbott Laboratories, Roche Diagnostics - openPR
Relyea Zuckerberg Hanson LLC Purchases 14,960 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Householder Group Estate & Retirement Specialist LLC - MarketBeat
Avanza Fonder AB Invests $20.64 Million in Abbott Laboratories (NYSE:ABT) - MarketBeat
Tompkins Financial Corp Buys 2,410 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Chemistry Wealth Management LLC Makes New $267,000 Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Declining Stock and Decent Financials: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)? - Yahoo Finance
Empirical Asset Management LLC Has $5.41 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Inspirion Wealth Advisors LLC - MarketBeat
Ritholtz Wealth Management Grows Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Carnegie Investment Counsel Increases Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Cardiac Marker Testing Market May See a Big Move | Abbott Laboratories, Thermo Fisher Scientific - openPR
Abbott Laboratories (ABT) to Release Earnings on Wednesday - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott pushes toddler milks that can cause health issues: lawsuit - New York Post
Abbott Laboratories (NYSE:ABT) Shares Sold by Gateway Investment Advisers LLC - MarketBeat
StrongBox Wealth LLC Raises Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Brady Family Wealth LLC Sells 2,687 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Baby formula maker sued for deceptively marketing sugar-filled milk - WWJ
St. Louis Financial Planners Asset Management LLC Invests $1.77 Million in Abbott Laboratories (NYSE:ABT) - MarketBeat
3,855 Shares in Abbott Laboratories (NYSE:ABT) Acquired by USA Financial Formulas - MarketBeat
Abbott Labs sued for allegedly misleading parents in toddler milk products - KHOU.com
Sawyer & Company Inc Lowers Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Websterrogers Financial Advisors LLC Takes $259,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Increased by Sendero Wealth Management LLC - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Boosted by Park Avenue Securities LLC - MarketBeat
Biomarker Research Services Market Projected To Witness Substantial Growth, 2025-2032:Abbott Laboratories, - EIN News
Abbott's Toddler Nutrition Drinks Aren't Healthy, Parents Claim - Law360
Abbott closes Cardiomems coverage saga with Medicare win - BioWorld Online
Abbott accused of deceiving parents with potentially harmful formula for toddlers - CBS News
Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch
Abbott, Novartis, Grifols Settle Patent Dispute Over DNA Replication Method - USA Herald
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - MSN
Jim Cramer on Abbott Laboratories (ABT): ‘Not Understood Very Well Because They’re Doing Tremendous Stuff When It Comes To Diabetes. People Don’t Seem To Care’ - Insider Monkey
Campbell Newman Asset Management Inc. Trims Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Founders Grove Wealth Partners LLC Invests $471,000 in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Purchases 7,307 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Acquired by Fifth Third Wealth Advisors LLC - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):